Table 2 Development Cohort Demographics (N = 393)

Age

 Median (IQR)

60

(51, 65)

47

(43, 51)

56

(49, 61)

37

(29, 46)

57

(49, 67)

54

(48, 65)

40

(33, 56)

54

(45, 63)

56

(48, 63)

 Range

40, 77

31, 57

23, 73

21, 65

20, 81

26, 94

21, 77

20, 81

23, 94

Sex, n (%)

 Male

17

(50%)

16

(84%)

56

(60%)

79

(80%)

27

(46%)

51

(58%)

96 (72%)

43

(55%)

107

(59%)

 Female

17

(50%)

3

(16%)

38

(40%)

20

(20%)

32

(54%)

37

(42%)

37 (28%)

35

(45%)

75

(41%)

Race, n (%)

 White

22

(67%)

10

(53%)

53

(58%)

5

(5.1%)

51

(88%)

43

(90%)

27 (20%)

61 (79%)

96

(69%)

 Black

1

(3.0%)

5

(26%)

30

(33%)

94

(95%)

2

3.4%)

1

(2.1%)

95 (72%)

7

(9.1%)

31

(22%)

 Hispanic

0

(0%)

2

(11%)

1

(1.1%)

0

(0%)

4

(6.9%)

2

(4.2%)

0 (0%)

6

(7.8%)

3

(2.1%)

 Asian

0

(0%)

1

(5.3%)

3

(3.3%)

0

(0%)

0

(0%)

0

(0%)

0 (0%)

1

(1.3%)

3

(2.1%)

 Other/Mixed Race

10

(30%)

1

(5.3%)

5

(5.4%)

0

(0%)

1

(1.7%)

2

(4.2%)

10 (7.6%)

2

(2.6%)

7

(5.0%)

 Unknown

1

0

2

0

1

40

1

1

42

Etiology, n (%)

—

—

—

 Viral

  HBV

0

(0%)

13

(14%)

0

(0%)

20

(23%)

0

(0%)

33

(18%)

  HCV

0

(0%)

41

(44%)

0

(0%)

22

(25%)

0

(0%)

63

(35%)

 Non-Viral

  Alcoholic Liver Disease

0

(0%)

0

(0%)

8

(14%)

0

(0%)

8

(10%)

0

(0%)

  Fatty Liver Disease

0

(0%)

0

(0%)

33

(56%)

0

(0%)

33

(42%)

0

(0%)

  Hemochromatosis

0

(0%)

0

(0%)

8

(14%)

0

(0%)

8

(10%)

0

(0%)

  Simple Steatosis

0

(0%)

0

(0%)

6

(10%)

0

(0%)

6

(7.7%)

0

(0%)

  Non-Viral Cirrhosis

0

(0%)

40

(43%)

0

(0%)

0

(0%)

0

(0%)

40 (22%)

 Unknown

19

(100%)

0

(0%)

4

(6.8%)

46

(52%)

23

(29%)

46

(25%)